NCT02258698View on ClinicalTrials.gov

Insulin Sensitivity, Irisin and Adipokines as Outcome Parameters in Patients Undergoing Cardiac Surgery

CompletedOBSERVATIONAL
Enrollment

348

Participants

Timeline

Start Date

May 31, 2013

Primary Completion Date

May 31, 2015

Study Completion Date

December 31, 2016

Conditions
Insulin ResistanceDiabetes Mellitus Type 2Other Functional Disturbances Following Cardiac Surgery
Interventions
PROCEDURE

Cardiac surgery

Blood samples for assessing Insulin resistance by HOMA, QUICKI, HbA1c, ANGPTL2, CXCL5, visfatin and irisin are drawn during induction of anesthesia, upon arrival on the intensive care unit and on postoperative day 1 and 3. Thirty days after surgery adverse outcomes covering all-cause morbidity and mortality will be assessed.

Trial Locations (1)

4031

Andrea Kopp Lugli, Basel

All Listed Sponsors
collaborator

McGill University

OTHER

lead

University Hospital, Basel, Switzerland

OTHER

NCT02258698 - Insulin Sensitivity, Irisin and Adipokines as Outcome Parameters in Patients Undergoing Cardiac Surgery | Biotech Hunter | Biotech Hunter